Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Investing

Sona Nanotech: Leveraging Nanotechnology in Colorectal Cancer Therapy

by October 19, 2023
October 19, 2023
Sona Nanotech: Leveraging Nanotechnology in Colorectal Cancer Therapy

Sona Nanotech (CSE:SONA, OTCQB:SNANF) advances nanotechnology medicine through its proprietary gold nanorods that promise to change the face of cancer therapy. Sona Nanotech’s platform technology leverages uniquely biocompatible gold nanorods (GNRs). Biocompatibility is key to the application of nanotechnology in medicine.

For the past several years, Sona has been working hard to develop and operationalize its biocompatible nanoparticle technology for use in targeted cancer therapy. The company is also developing a targeted cancer therapy, leveraging its proprietary Targeted Hyperthermia Therapy (THT) to directly treat cancer cells.

Sona’s GNRs are rod-shaped nanoparticles made of gold and measuring from 10 to 100 nanometers in length. Produced by chemical synthesis, they directly address many of the current limitations of medical nanoparticle technologies. In addition to making them well-suited for cancer treatment, this also unlocks their potential for use in in-vivo medical applications.

Company Highlights

Canadian nanotechnology company, Sona Nanotech has developed an incredibly promising new technology that leverages uniquely biocompatible gold nanorods.The company also plays a key role in the advancement of photothermal medical therapies, particularly enabled by the company’s acquisition of Siva Therapeutics.This acquisition has allowed Sona to advance the development of Targeted Hypothermia Therapy, addressing many of the risks with current cancer treatments — particularly the damage they can cause to other tissues.THT has already proven effective in reducing tumors in small animal studies. Sona’s initial target for the technology will be colorectal cancer.Rapid diagnostic tests represent the company’s other strategic area of focus, including bovine tuberculosis detection and concussion screening.Future applications for Sona’s technology could include:Targeted drug deliveryPhotothermal cosmetic therapyCell imagingAdditional proprietary testing solutions supported by third-party test development services.The company’s leadership and board of directors comprise experienced professionals from across the healthcare and biotechnology sectors.Sona has a clear roadmap to commercialization of its treatment methodology, starting with a near-term catalyst in large animal studies before moving to a human pilot. It also expects a De Novo pathway for medical devices.

This Sona Nanotech is part of a paid investor education campaign.*

Click here to connect with Sona Nanotech (CSE:SONA) to receive an Investor Presentation

This post appeared first on investingnews.com

0
FacebookTwitterGoogle +Pinterest
previous post
In rare move, Ford executive chair calls on UAW to make a deal and end ‘acrimonious’ talks
next post
Appia Rare Earths & Uranium

Related Posts

5 Artificial Intelligence ETFs

January 18, 2024

Prismo Metals

August 10, 2023

Lithium Consolidation, Strongly Supported $3M Placement and Strategic...

December 19, 2023

Top 5 Canadian Mining Stocks This Week: GPM...

March 1, 2025

Lancaster Resources Announces Spin-Off Agreement with Subsidiary and...

January 4, 2024

John Feneck: Gold Due for Sector Rotation, 10+...

October 3, 2023

Edjudina Gold Project, WA – Permitting Application to...

March 26, 2025

5 Top Weekly TSXV Stocks: Timberline Gains 120...

April 22, 2024

Operator XR – Sales Update June 24

July 4, 2024

Sona Nanotech Secures Grant Funding to Support Intellectual...

April 9, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Run Your Stock Portfolio Like a Pro Sports Team

    • Leadership Rotation Could Confirm Corrective Phase

    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

    • 1911 Gold Temporarily Suspends Operations at True North Complex due to Bissett Evacuation Order

    • Ontario Backs Down on Key Bill 5 Provisions, Echoes BC’s Mining Debate

    • Appeals Court Grants Trump Temporary Reprieve on Tariffs, “TACO” Taunts Gain Steam

    Categories

    • Business (1,223)
    • Investing (2,503)
    • Politics (3,699)
    • Stocks (1,614)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved